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T HE INCREASING clinical use of hexamethonium, a ganglion blocking agent, makes desirable a detailed knowledge of its acute hemodynamic effects in normotensive man. Recent work on dogs 1 ' 2 indicates that the hexamethonium-induced fall in arterial pressure is accompanied by significant decrease in cardiac output with increase in the calculated total peripheral resistance. Accordingly, the authors concluded that the decrease in arterial pressure was due to the reduction in the cardiac output. Such findings require confirmation in humans. The present investigation was designed to serve this purpose.
MATERIAL AND METHODS
Eighteen normal subjects free of cardiac or pulmonary disease, infection or fever were selected from the medical wards. Following light sedation, routine dextrocardiao catheterization was performed in an ambient temperature of 24 C. Central venous pressures transduced via Statham strain gages, and brachial arterial pressures, measured through an indwelling arterial needle, were simultaneously inscribed with an electrocardiogram on a Brush sixchannel oscillograph. Mean pressures were derived by planimetries integration of two consecutive respiratory cycles. Left ventricular work as well as total peripheral and pulmonary resistance was calculated by conventional formulas.
All blood specimens were withdrawn in duplicate and oxygen contents were determined spectrophotometrically. 3 The maximal variation allowed between checks was ±0.2 volumes per cent. Expired air, measured through a dry gas test meter, was collected From the Department of Medicine, Western Reserve University at City Hospital, Cleveland, Ohio.
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in Douglas bags (four minutes), and the oxygen content obtained by passage through the Pauling oxygen analyzer. All volumes were corrected to standard temperature and pressure. The maximal difference allowed between two successive oxygen consumption and cardiac output check determinations was 10 per cent (steady state). Following basal determinations, hexamethonium was administered intravenously at a rate of 1 mg. per minute for 10 minutes; dosage and rate of administration were grossly doubled thereafter until a noticeable decrease in brachial arterial pressure was observed. In three patients receiving a total of 120 nig., the last 50 mg. were injected at a rate of 10 mg. per minute. The total dosage varied from 15 to 120 mg. Basal studies were repeated 30 minutes following termination of injection.
The following changes from the basal during the experimental period were considered significant: (a) 20 per cent for mean brachial artery pressure, (b) more than 10 per cent for cardiac index, (c) more than 15 beats per minute for heart rate, (d) 5 mm. Hg for pulmonary artery pressure, and (e) 20 per cent for calculated resistances and left ventricular work.
Complete data are presented in 10 of 12 patients; the other six were eliminated from the documentation because of failure to maintain a steady state or poor blood analysis checks.
RESULTS AND DISCUSSION
Pertinent data are presented in table 1. 1. Brachial artery pressure tended to decrease in all patients except D. B. In the latter, a larger dose might have been effective, since there was great variation in dosage-response.
2. Pulmonary artery pressure tended to decrease in nine subjects; there was an insignificant rise in three subjects.
3. The cardiac index increased in three, decreased in three, and was unaltered in four individuals. The average change for the entire group was +0.8 per cent.
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4. Tlcart rate rose in all subjects except one (L. B.) in whom an insignificant fall was noted.
5. Total peripheral resistance decreased in noted in II. G., and was dissociated from the changes in T.P.R. and cardiac index. 7. Left ventricular work was reduced in nine all patients except one (D. B.) in whom a negligible increase occurred.
0 Total pulmonary artery resistance decreased in seven subjects; two showed a negligible rise. A slight and unexplained rise was patients; a negligible increase due to a significant rise in cardiac index was noted in J. H.
Basal peripheral arterial oxygen saturation values (range: 94 to 96.5 per cent) were unchanged. The form of the electrocardiograms^ was unaltered except for changes produced by variations in heart rate.
The data demonstrate that there is no direct relationship between the changes in cardiac index and those that occur in the arterial blood pressure. Rather, there is a tendency for pulmonary and peripheral arterial pressures, pulmonary and total peripheral resistances, and the mechanical work of the left ventricle to decrease. The differences between these findings and those in anesthetized normotensive and renal hypertensive dogs 1 ' 2 is emphasized by subjects W. J., F. P., J. H. in which definite decreases in arterial pressure were attended by increases in the cardiac index and reductions in calculated resistance. In other cases (A. R., E. H., L. B.), despite a decrease in the cardiac index, calculated resistance still was lowered. On the average, the cardiac index underwent no change, whereas the other modalities measured showed borderline significant percentile alterations.
The action of hexamethonium in man appears to differ from that reported in dogs. The conclusion germane to the dog data, that decrease in cardiac output is responsible for fall in arterial pressure does not apply to man. With dosage at times greater than that administered to dogs, hexamethonium in man produced a fall in peripheral arterial pressure purely as a result of ganglion blockade, with variable changes in the cardiac output. The varying degree of tachycardia usually encountered altered the total output changes. Our findings corroborate the undocumented report of Freis and associates. 4 There is much Individual variability in dose-response. Had our object been to produce a standard fall in blood pressure, greater reductions might have resulted. From the standpoint of caution, we ceased administration of the drug pursuant to a noticeable decrease in peripheral arterial pressure, and did not feel justified in continued administration in the face of a definite tachycardia.
SUMMARY AND CONCLUSIONS 1. Hexamethonium bromide was administered intravenously to 12 normotensive individuals in a steady state. Complete data are presented for 10 of these subjects.
2. Changes in cardiac output are variable, and the heart rate is generally increased. Brachial and pulmonary artery pressure, and calculated total peripheral and pulmonary resistances, and left ventricular work undergo an over-all decrease. There is marked individual variation in dose-response.
3. These data indicate that hexamethonium lowers arterial pressure in normotensive man primarily by diminishing total peripheral resistance, rather than by diminishing cardiac output.
